Ribonucleic acid (RNA) molecules may be best known for their job ferrying the genetic information encoded in DNA to a cell's ...

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...

In this valuable study, the authors demonstrate that TCF7L2 plays a role in the pathogenesis of cachexia in a mouse model of GI cancer. The results are solid, although future studies will need further ...

Mindera Health, a leader in precision medicine for dermatological conditions, today announced positive results from the completion of a randomized, prospective clinical trial (MATCH) aimed at ...

What lives off the Northwest coasts of Spain and shrinks to one-fifth of its size when alarmed? Enter the accordion worm.

QIAGEN N.V. today announced that its Supervisory Board intends to elect Stephen H. Rusckowski to succeed Lawrence A. Rosen as Chairman of the Supervisory Board following its Annual General Meeting on ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its Supervisory Board will propose the ...

Net sales of $483 million (+5% actual rates, +7% constant exchange rates, CER); adjusted diluted EPS of $0.55 Net sales ...

faster and more reliable DNA manufacturing pipeline,” said Matt Hill, Founder and CEO of Elegen. “It removes major bottlenecks in RNA therapy development—especially for personalized cancer vaccines ...

The majority of RNAs in each of our cells don't code for any of the thousands of proteins that make up our bodies. Instead, ...

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...